SCHEMBL204828

SCHEMBL204828

COC(=O)[C@H](N)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135981 1.00
SCHEMBL135982 1.00
Ammonia Solution, Strong SCHEMBL27488505 0.97 SMN1; SMN2 (0.48)
SCHEMBL2239379 0.97 SMN1; SMN2 (0.48)
Hydrochloric Acid SCHEMBL203200 0.97 SMN1; SMN2 (0.48)
Bromide SCHEMBL28463120 0.97 SMN1; SMN2 (0.48)
Bromide SCHEMBL28463121 0.97 SMN1; SMN2 (0.48)
Hydrochloric Acid SCHEMBL345942 0.97 SMN1; SMN2 (0.48)
Hydrochloric Acid SCHEMBL261172 0.97 SMN1; SMN2 (0.48)
Acetic Acid SCHEMBL28031091 0.93 SLC7A5 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346553-A1 Process for the Preparation of R-Oxybutynin Hydrochloride HARMAN FINOCHEM LTD (IN) 2025-11-13 US claimed
EP-4519242-A1 PROCESS FOR THE PREPARATION OF R-OXYBUTYNIN HYDROCHLORIDE Harman Finochem Limited (IN) 2025-03-12 EP claimed
CN-112047998-B Preparation method of perindopril 上海阿达玛斯试剂有限公司 2024-01-09 CN claimed
WO-2023214426-A1 PROCESS FOR THE PREPARATION OF R-OXYBUTYNIN HYDROCHLORIDE HARMAN FINOCHEM LIMITED (IN) 2023-11-09 WO claimed
CN-116947879-A BBI608 derivative, preparation method thereof and application thereof in preparing medicines for treating STAT3 mediated diseases 沈阳药科大学 2023-10-27 CN claimed
CN-113527399-B Ginsenoside CK derivative and application thereof in preparation of antitumor drugs 陕西巨子生物技术有限公司 2023-01-31 CN claimed
CN-114502543-A Targeted protein compounds, pharmaceutical compositions and therapeutic applications thereof 拜欧斯瑞克斯公司 2022-05-13 CN claimed
WO-2022041126-A1 GLYCYRRHIZIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 林振文 2022-03-03 WO claimed
CN-113527399-A Ginsenoside CK derivative and application thereof in preparation of antitumor drugs 陕西巨子生物技术有限公司 2021-10-22 CN claimed
CN-112047998-A Preparation method of perindopril 上海阿达玛斯试剂有限公司 2020-12-08 CN claimed
CN-106554307-B Preparation method of antiviral quinolinone alkaloid derivative from marine fungi 扬州蓝色生物医药科技有限公司 2019-09-27 CN claimed
CN-103193669-A nNOS-Capon uncoupling compound, preparation method and application thereof UNIV NANJING MEDICAL 2013-07-10 CN claimed
EP-0620813-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF AND ANGIOTENSIN II BRITISH BIO-TECHNOLOGY LIMITED (GB) 1994-10-26 EP claimed
WO-1993014069-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF AND ANGIOTENSIN II BRITISH BIO-TECHNOLOGY LIMITED (GB) 1993-07-22 WO claimed
EP-4142732-B1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2026-04-22 EP disclosed
US-20260091082-A1 CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING EYE DISEASE DKS CO. LTD. (JP) 2026-04-02 US disclosed
EP-4274572-B1 NOVEL INHIBITORS OF AUTOTAXIN ZYDUS LIFESCIENCES LTD (IN) 2026-02-18 EP disclosed
US-4487717-A PHASE SEPARATION USING ORGANIC SOLVENT TOYO SODA MANUFACTURING CO., LTD. (JP) 1984-12-11 US disclosed
EP-0086053-A1 Process for synthesizing peptides or peptide derivatives Imahori, Kazutomo (JP) 1983-08-17 EP disclosed
EP-0075160-A2 Process for recovering a dipeptide derivative TOYO SODA MANUFACTURING CO., LTD. (JP) 1983-03-30 EP disclosed